Protein kinase C-dependent NAD(P)H oxidase activation induced by type 1 diabetes in renal medullary thick ascending limb

Hypertension

Volumn 55, Issue 2, 2010, Pages 468-473

  Yang, Jing ^a   Lane, Pascale H ^a   Pollock, Jennifer S ^b   Carmines, Pamela K ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b MEDICAL COLLEGE OF GEORGIA   (United States)

Author keywords

NAD(P)H oxidase; Protein kinase C; Thick ascending limb; Type 1 diabetes

Indexed keywords

APOCYNIN; CALPHOSTIN C; PROTEIN KINASE C ALPHA; PROTEIN KINASE C BETA; PROTEIN P47; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4; ROTTLERIN; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVATION; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY TUBULE; NONHUMAN; PRIORITY JOURNAL; RAT; RENAL MEDULLARY THICK ASCENDING LIMB; STREPTOZOCIN DIABETES;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; KIDNEY MEDULLA; MALE; NADPH OXIDASE; PROBABILITY; PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES;

EID: 74949119895     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.109.145714     Document Type: Conference Paper

References (40)

1. Li JM, Shah AM. ROS generation by nonphagocytic NADPH oxidase: potential relevance in diabetic nephropathy. J Am Soc Nephrol. 2003;14: S221-S226.
2. Forbes JM, Coughlan MT, Cooper ME. Oxidative stress as a major culprit in kidney disease in diabetes. Diabetes. 2008;57:1446-1454.
3. West IC. Radicals and oxidative stress in diabetes. Diabet Med. 2000;17: 171-180.
4. Li N, Yi FX, Spurrier JL, Bobrowitz CA, Zou AP. Production of superoxide through NADH oxidase in thick ascending limb of Henle's loop in rat kidney. Am J Physiol Renal Physiol. 2002;282:F1111-F1119.
5. Yang J, Lane PH, Pollock JS, Carmines PK. PKC-dependent superoxide production by the renal medullary thick ascending limb from diabetic rats. Am J Physiol Renal Physiol. 2009;297:F1220-F1228.
6. Zou AP, Li N, Cowley AW Jr. Production and actions of superoxide in the renal medulla. Hypertension. 2001;37:547-553.
7. Vaziri ND. Roles of oxidative stress and antioxidant therapy in chronic kidney disease and hypertension. Curr Opin Nephrol Hypertens. 2004; 13:93-99.
8. Gao L, Mann GE. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling. Cardiovasc Res. 2009;82:9-20.
9. Asaba K, Tojo A, Onozato ML, Goto A, Quinn MT, Fujita T, Wilcox CS. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005;67:1890-1898.
10. phox by protein kinase C-/3 activation is required for oxidative stress in diabetic nephropathy. Diabetes. 2003;52:2603-2614.
11. Etoh T, Inoguchi T, Kakimoto M, Sonoda N, Kobayashi K, Kuroda J, Sumimoto H, Nawata H. Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment. Diabe-tologia. 2003;46:1428-1437.
12. Igarashi M, Wakasaki H, Takahara N, Ishii H, Jiang ZY, Yamauchi T, Kuboki K, Meier M, Rhodes CJ, King GL. Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways. J Clin Invest. 1999;103:185-195.
13. Craven PA, DeRubertis FR. Protein kinase C is activated in glomeruli from streptozotocin diabetic rats. Possible mediation by glucose. J Clin Invest. 1989;83:1667-1675.
14. Inoguchi T, Xia P, Kunisaki M, Higashi S, Feener EP, King GL. Insulin's effect on protein kinase C and diacylglycerol induced by diabetes and glucose in vascular tissues. Am J Physiol Endocrinol Metab. 1994;267: E369-E379.
15. Koya D, Jirousek MR, Lin YW, Ishii H, Kuboki K, King GL. Characterization of protein kinase C /3 isoform activation on the gene expression of transforming growth factor-/3, extracellular matrix components, and prostanoids in the glomeruli of diabetic rats. J Clin Invest. 1997;100: 115-126.
16. Silva G, Beierwaltes WH, Garvin JL. Extracellular ATP stimulates NO production in rat thick ascending limb. Hypertension. 2006;47:563-567.
17. 2-and is diminished by a high-salt diet. Am J Physiol Renal Physiol. 2004;287:F224-F230.
18. Keenan C, Goode N, Pears C. Isoform specificity of activators and inhibitors of protein kinase C y and 8. FEBS Lett. 1997;415:101-108. (Pubitemid 27402058)
19. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem. 1993;268: 9194-9197.
20. Tanaka M, Sagawa S, Hoshi Ji, Shimoma F, Matsuda I, Sakoda K, Sasase T, Shindo M, Inaba T. Synthesis of anilino-monoindolylmaleimides as potent and selective PKC/3 inhibitors. Bioorg Med Chem Lett. 2004;14: 5171-5174.
21. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun. 1994;199:93-98.
22. Dominguez C, Ruiz E, Gussinye M, Carrascosa A. Oxidative stress at onset and in early stages of type 1 diabetes in children and adolescents. Diabetes Care. 1998;21:1736-1742.
23. Sasser JM, Sullivan JC, Hobbs JL, Yamamoto T, Pollock DM, Carmines PK, Pollock JS. Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism. J Am Soc Nephrol. 2007;18: 143-154.
24. Lee DL, Sasser JM, Hobbs JL, Boriskie A, Pollock DM, Carmines PK, Pollock JS. Posttranslational regulation of NO synthase activity in the renal medulla of diabetic rats. Am J Physiol Renal Physiol. 2005;288: F82-F90.
25. Palm F, Ortsater H, Hansell P, Liss P, Carlsson PO. Differentiating between effects of streptozotocin per se and subsequent hyperglycemia on renal function and metabolism in the streptozotocin-diabetic rat model. Diabetes Metab Res Rev. 2004;20:452-459.
26. Heumüller S, Wind S, Barbosa-Sicard E, Schmidt HH, Busse R, Schroder K, Brandes RP. Apocynin is not an inhibitor of vascular NADPH oxidases but an antioxidant. Hypertension. 2008;51:211-217.
27. Simons JM, Hart BA, Ip Vai Ching TR, Van DH, Labadie RP. Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils. Free Radic Biol Med. 1990;8:251-258.
28. Haegens A, Vernooy JHJ, Heeringa P, Mossman BT, Wouters EFM. Myeloperoxidase modulates lung epithelial responses to proinflammatory agents. Eur Respir J. 2008;31:252-260.
29. Vejrazka M, Micek R, Stipek S. Apocynin inhibits NADPH oxidase in phagocytes but stimulates ROS production in non-phagocytic cells. Biochim Biophys Acta. 2005;1722:143-147.
30. Brandes RP, Schroder K. Differential vascular functions of Nox family NADPH oxidases. Curr Opin Lipidol. 2008;19:513-518.
31. Block K, Gorin Y, Abboud HE. Subcellular localization of Nox4 and regulation in diabetes. Proc Natl Acad Sci USA. 2009;106:14385-14390.
32. Gorin Y, Block K, Hernandez J, Bhandari B, Wagner B, Barnes JL, Abboud HE. Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney. J Biol Chem. 2005;280: 39616-39626.
33. Inoguchi T, Li P, Umeda F, Yu HY, Kakimoto M, Imamura M, Aoki T, Etoh T, Hashimoto T, Naruse M, Sano H, Utsumi H, Nawata H. High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C-dependent activation of NAD(P)H oxidase in cultured vascular cells. Diabetes. 2000;49:1939-1945.
34. phox phosphorylation and translocation in activated human monocytes. J Immunol. 2004;174:5730-5738.
35. Xu H, Goettsch C, Xia N, Horke S, Morawietz H, Forstermann U, Li H. Differential roles of PKCa and PKCe in controlling the gene expression of Nox4 in human endothelial cells. Free Radic Biol Med. 2008;44: 1656-1667.
36. Rasch R, Torffvit O, Bachmann S, Jensen PK, Jacobsen NO. Tamm-Horsfall glycoprotein in streptozotocin diabetic rats: A study of kidney in situ hybridization, immunohistochemistry, and urinary excretion. Diabetologia. 1995;38:525-535.
37. Sejdiu I, Torffvit O. Decreased urinary concentration of Tamm-Horsfall protein is associated with development of renal failure and cardiovascular death within 20 years in type 1 but not in type 2 diabetic patients. Scand J Urol Nephrol. 2008;42:168-174.
38. 2 and NO in the thick ascending limb. Hypertension. 2002;39:591-596.
39. Ortiz PA, Garvin JL. Superoxide stimulates NaCl absorption by the thick ascending limb. Am J Physiol Renal Physiol. 2002;283:F957-F962.
40. Foster JM, Carmines PK, Pollock JS. PP2B-dependent NO production in the medullary thick ascending limb during diabetes. Am J Physiol Renal Physiol. 2009;297:F471-F480.